conflict of interest
Jump to navigation
Jump to search
Management
- forego gifts from pharmaceutical, medical device & biotechnology companies
- accept only payment at fair market value for legitimate service
- do not make educational presentations or publish scientific articles that are controlled by industry
- do not meet with pharmaceutical or medical device sales representatives except by appointment at a physician's request
- do not accept drug samples except in certain situations for patients who lack financial access to medications
Notes
- perceptions of conflict of interest are as important as actual conflicts of interest[5]
- The Open Payments Search Tool is used to search payments made by drug & medical device companies to physicians & teaching hospitals[6]
Additional terms
References
- ↑ Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
- ↑ Rockey SJ, Collins FS. Managing financial conflict of interest in biomedical research. JAMA. 2010 Jun 16;303(23):2400-2 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20498237
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 11, 17. American College of Physicians, Philadelphia 1998, 2015
- ↑ Brennan TA, Rothman DJ, Blank L et al Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006 Jan 25;295(4):429-33. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16434633
- ↑ 5.0 5.1 Yancy CW, Harrington RA, Bonow RO. Author Relationships With Industry. Policies and Procedures for Authors and Editors of JAMA Cardiology JAMA Cardiol. Published online September 27, 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28973086 <Internet> http://jamanetwork.com/journals/jamacardiology/article-abstract/2654954
- ↑ 6.0 6.1 OpenPaymentsData.CMS.gov https://openpaymentsdata.cms.gov/